Cargando…
Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation
SIMPLE SUMMARY: PTEN is a protein highly altered in endometrial cancer. PTEN mutation or deficiency leads to the activation of other downstream proteins that are important to the development of cancers. In this study, we have identified the SMAD2/3 proteins as targets of PTEN deficiency. We have fou...
Autores principales: | Eritja, Núria, Navaridas, Raúl, Ruiz-Mitjana, Anna, Vidal-Sabanés, Maria, Egea, Joaquim, Encinas, Mario, Matias-Guiu, Xavier, Dolcet, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507901/ https://www.ncbi.nlm.nih.gov/pubmed/34638474 http://dx.doi.org/10.3390/cancers13194990 |
Ejemplares similares
-
Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition
por: Ruiz-Mitjana, Anna, et al.
Publicado: (2022) -
In Vivo Intra‐Uterine Delivery of TAT‐Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53‐Deficient Endometrial Cancers
por: Navaridas, Raúl, et al.
Publicado: (2023) -
Transient and DNA‐free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis
por: Navaridas, Raúl, et al.
Publicado: (2023) -
An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias
por: Mirantes, Cristina, et al.
Publicado: (2013) -
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
por: Eritja, Núria, et al.
Publicado: (2017)